Hepatitis C virus (HCV) infection is a major global health ... The tremendous activity in anti-HCV drug development needs to be extended to HCV vaccine development. Continued research activities ...
Human studies to date suggest that this is a realistic goal. Table 1. Recombinant protein hepatitis C vaccine studies. Structure (Investigator) Phase (year) Subjects Outcome Ref. HCV E1 + alum ...
New data from the Allegheny County Health Department shows sharp increases in rates of pertussis, Hepatitis C, and other ...
Hepatitis B and C still survive in the dark, driven by a lack of information, unhygienic medical procedures, and poor access ...
A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...
with the development of a cure for hepatitis C, vaccines for hepatitis A, B and E, and effective treatments for hepatitis A and B. (Read more in related content, below). In addition, there has ...
Hepatitis C test guidelines led to more screenings in women, especially in pregnancy, but not enough
"From 1998 to 2018, hepatitis C virus (HCV) prevalence increased from 0.34 to 5.3 cases per 1,000 pregnancies," the authors ...
The National Childhood Vaccine Injury Act of 1986 removed the economic incentive that held vaccine developers accountable for vaccine safety. Reforms, including properly designed trials, are needed to ...
People should get the vaccine within 14 days of exposure ... jaundice or elevated serum aminotransferase levels and (c) [who] tested positive for hepatitis A (IgM anti-HAV-positive), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback